Published in
Elsevier, Digestive and Liver Disease, 11(54), p. 1563-1572, 2022
DOI: 10.1016/j.dld.2022.07.003
Links
Tools
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors
Journal article published in 2022 by
Benedetta Stefanini 
,
Laura Bucci,
Valentina Santi,
Nicola Reggidori,
Davide Rampoldi,
Lorenzo Lani,
Alessandro Granito,
Angelo Sangiovanni,
Giuseppe Cabibbo,
Fabio Farinati,
Claudia Campani,
Francesco Giuseppe Foschi,
Gianluca Svegliati-Baroni,
Giovanni Raimondo,
Antonio Gasbarrini
and other authors.
,
Laura Bucci,
Valentina Santi,
Nicola Reggidori,
Davide Rampoldi,
Lorenzo Lani,
Alessandro Granito,
Angelo Sangiovanni,
Giuseppe Cabibbo,
Fabio Farinati,
Claudia Campani,
Francesco Giuseppe Foschi,
Gianluca Svegliati-Baroni,
Giovanni Raimondo,
Antonio Gasbarrini
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 